文献速递癫痫神经重症与神经感染

癫痫患者感染COVID-19及发生严重并发症的风险:一项全国性队列研究

Risk of COVID-19 Infection and of Severe Complications Among People With Epilepsy: A Nationwide Cohort Study.
PubMed 文献 · Neurology · 2022-03-25

该全国性队列研究纳入2020年1月1日至6月4日期间接受SARS-CoV-2 RT-PCR检测的212,678名韩国参与者,其中3,919人(1.8%)有癫痫史。倾向评分匹配后,癫痫史与COVID-19 PCR阳性无显著关联(OR 0.86,95%CI 0.67-1.11);在7,713例确诊COVID-19患者中,癫痫史与严重并发症发生相关(OR 2.05,95%CI 1.04-4.04),但与死亡率无显著关联(OR 1.55,95%CI 0.65-3.70)。

要点

  • 癫痫史与COVID-19感染易感性无显著关联(OR 0.86,95%CI 0.67-1.11)。
  • 确诊COVID-19的癫痫患者发生严重并发症的风险升高(OR 2.05,95%CI 1.04-4.04)。
  • 癫痫史与COVID-19相关死亡率无显著关联(OR 1.55,95%CI 0.65-3.70)。

核心结论

  • 癫痫史与COVID-19感染易感性升高及感染相关死亡率无关,但与COVID-19严重并发症风险升高相关;作者认为因此可能需要仔细管理和监测。

研究设计与样本

  • 韩国全国性COVID-19数据集队列研究,纳入2020年1月1日至6月4日期间至少接受1次SARS-CoV-2实时逆转录PCR检测的212,678名参与者。
  • 癫痫根据COVID-19诊断前健康索赔数据中的诊断代码定义。
  • 采用1:6比例倾向评分匹配(PSM)和逻辑回归分析评估癫痫与COVID-19易感性或严重并发症的关联。
  • 严重并发症定义为COVID-19诊断后2个月内机械通气、重症监护室入住和死亡的复合终点。

主要发现

  • 212,678名参与者中3,919人(1.8%)有癫痫史。
  • PSM后,癫痫史与COVID-19 PCR阳性无显著差异(OR 0.86,95%CI 0.67-1.11)。
  • 7,713例确诊COVID-19感染患者中72人(0.9%)有癫痫史;COVID-19患者中444人(5.8%)发生严重并发症。
  • PSM后,癫痫史与COVID-19感染后严重并发症发生相关(OR 2.05,95%CI 1.04-4.04)。
  • COVID-19感染后死亡率按癫痫史无差异(OR 1.55,95%CI 0.65-3.70)。

临床怎么用

  • 作者认为,癫痫患者感染COVID-19后严重并发症风险升高,因此可能需要仔细管理和监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The goal of this work was to evaluate whether patients with epilepsy were more susceptible to coronavirus disease 2019 (COVID-19) infection and at greater risk of severe complications when infected with COVID-19 compared with patients without epilepsy. METHODS: We included participants who underwent at least 1 severe acute respiratory syndrome coronavirus 2 real-time reverse-transcription PCR test between January 1 and June 4, 2020, from the Korean nationwide COVID-19 dataset. Epilepsy was defined according to the presence of diagnostic code in health claims data before the COVID-19 diagnosis. To investigate the association between epilepsy and the susceptibility for or severe complications of COVID-19, a 1:6 ratio propensity score matching (PSM) and logistic regression analysis were performed. Severe complications with COVID-19 infection were defined as a composite of the incidence of mechanical ventilation, intensive care unit admission, and death within 2 months after COVID-19 diagnosis. RESULTS: Among 212,678 study participants who underwent a COVID-19 test, 3,919 (1.8%) had a history of epilepsy. After PSM, there was no significant difference in COVID-19 PCR positivity according to epilepsy history (odds ratio [OR] 0.86, 95% CI 0.67-1.11). Of the 7,713 individuals with confirmed COVID-19 infection, 72 (0.9%) had a history of epilepsy. Among the patients with COVID-19, severe complications occurred in 444 (5.8%) individuals. After PSM, the presence of epilepsy was associated with the occurrence of severe complications after COVID-19 infection (OR 2.05, 95% CI 1.04-4.04). Mortality after COVID-19 infection did not differ according to the presence of epilepsy history (OR 1.55, 95% CI 0.65-3.70). DISCUSSION: The presence of epilepsy was not associated with increased susceptibility to COVID-19 infection or mortality related to the infection. However, there was an increased risk of severe complications with COVID-19 in patients with epilepsy; therefore, careful management and monitoring may be necessary.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Yoo J, Kim JH, Jeon J, et al. Risk of COVID-19 Infection and of Severe Complications Among People With Epilepsy: A Nationwide Cohort Study. Neurology. 2022. PMID: 35338078. doi:10.1212/WNL.0000000000200195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。